SCHEMBL31661769

SCHEMBL31661769

O=C(O)CCCCCCCC(=O)Nc1cc(Cl)ccc1O

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.69
ALOX15 P16050 1/20 0.66
MAPK1 P28482 1/20 0.66
GAA P10253 3/20 0.62
ALDH1A1 P00352 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
HPGD P15428 1/20 0.55
KDM4E B2RXH2 1/20 0.55
KCNMA1 Q12791 4/20 0.54
STAT3 P40763 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
LMNA P02545 1/20 0.49
RAB9A P51151 1/20 0.49
HDAC1 Q13547 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656576 1.00 POLB (0.69) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL3046406 1.00 POLB (0.69) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL7717051 1.00 POLB (0.69) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL7718043 1.00 POLB (0.69) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL7719057 0.95 POLB (0.71) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL13593325 0.90 POLB (0.55) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL13593333 0.90 POLB (0.55) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL13166882 0.89 POLB (0.76) POLBALOX15MAPK1GAATDP1
SCHEMBL31661644 0.88 POLB (0.56) POLBALOX15MAPK1GAAALDH1A1
SCHEMBL5655283 0.88 POLB (0.56) POLBALOX15MAPK1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed